# Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS

Study · id `cardio:ct-nct01515878` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01515878](<https://clinicaltrials.gov/study/NCT01515878>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01515878

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 396 participants.

## Technical summary

Registry record NCT01515878. Randomized; no masking; primary purpose prevention. Start 2012-02 (registry gives no type); primary completion 2015-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 396 participants (planned count; ClinicalTrials.gov record NCT01515878, source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01515878, source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)
- Primary completion: 2015-03 (anticipated) (ClinicalTrials.gov record NCT01515878, source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)
- Completion: 2015-03 (anticipated) (ClinicalTrials.gov record NCT01515878, source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)
- Countries: Canada; France; Italy (ClinicalTrials.gov record NCT01515878, source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01515878-2012-07-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS
- Acronym: HERACLES
- Condition: Kidney Failure Chronic
- Condition: Cardiovascular Diseases
- Intervention (Device): Hemocontrol
- Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna (`cardio:org-irccs-azienda-ospedaliero-universitaria-di-bologna`)

## Provenance

Content hash: cc851816ec099ade98931f89941df6af67038e4ed1f1607dd412965ea3d51e2b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
